期刊文献+

高血压患者胰岛素抵抗与超敏C-反应蛋白及纤维蛋白原的关系 被引量:3

Study on relation of insulin resistance with hyper-sensitivity C-reaction protein and fibrinogen in the patients with essential hypertension.
下载PDF
导出
摘要 目的探讨高血压患者胰岛素抵抗与超敏C-反应蛋白(hsCRP)及纤维蛋白(Fg)的关系。方法选择65例原发性高血压患者,用胰岛素抵抗指数(IRI)作为胰岛素敏感性评价指标,把单纯高血压患者分为高血压无胰岛素抵抗组(A组,21例)和高血压胰岛素抵抗组(B组,20例),而高血压合并2型糖尿病组(C组,24例),采集空腹静脉血,测定3组患者hsCRP以及Fg、血糖、胰岛素、血脂和载脂蛋白。结果B组及C组hsCRP和Fg水平高于A组(P<0.05)。Logistic回归分析显示:IRI与Fg和hsCRP呈正相关(OR分别是2.901,1.318,均P<0.01)。结论hsCRP和Fg反映出机体炎症活性,在原发性高血压的胰岛素抵抗及2型糖尿病发病机制中可能起一定作用。 Objective To study on relation of insulin resistance with hyper-seasitivity C-reaction protein( hsCRP) and fibrinogen ( Fg) in the patients with essential hypertension. Methods 65 cases of EH were selected, IRI was applied to estimate insulin resistance, essential hypertension patients without type 2 diabetes mellitus were divided into non IR group(group A, n = 21 )and IR group(group B, n = 20), 24 cases of EH with T2 DM were group C, hsCRP. Fg.fasting glucose.fasting insulin, blood lipid and lipoprotein were measured after 12h over night fast. Results The serum levels of hsCRP and Fg in group B and C were higher than ones in group A( P 〈 0.05). Logistic regression analysis showed that IRI was positively correlated with Fg and hsCRP( OR = 2.901.1.318,both P 〈 0.01 ). Conclusion hsCRP and Fg may be useful markers of systemic inflammation,The serum levels may play role in essential hypertension with insulin resistance and type 2 diabetes mellitus.
出处 《四川医学》 CAS 2007年第5期499-501,共3页 Sichuan Medical Journal
关键词 原发性高血压 胰岛素抵抗 超敏C-反应蛋白 纤维蛋白原 essential hypertension insulin resistance hyper-sensitivity C-reaction protein fibrinogen
  • 相关文献

参考文献11

  • 1Hak AE,Pols HA,Stehouwer CD,et al.Markers d inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly:the rotterdam study[J].J Clin Endocrinol Metab,2001,86(9):4398~4405
  • 2严毓勤,胡靖超,吴士尧.他汀类药物早期干预对急性冠脉综合征患者血脂、高敏C反应蛋白和纤维蛋白原的影响[J].上海医学,2003,26(9):645-647. 被引量:9
  • 3Ikeda Y,Suehiro T,Nakamura T,et al.Clinical significance of the insulin resistance index as assessed by homeostasis model assessment[ J ].Endocrine,2001,48(1):81~86
  • 4侯春兰,李步荣,刘静,张新雅.2型糖尿病及胰岛素抵抗与细胞因子的相关性研究[J].第四军医大学学报,2006,27(11):997-998. 被引量:14
  • 5Duncan BB,Schmidt MI.Chronic activation of the innate immune system may underlie the metabolic syndrome[J] Sao Paulo Med J,2001,119(3):122~127
  • 6John A,Colwell MD.Inflammation and diabetic vascular complications[J].Diabetes Care,1999,22(12):1927~1928
  • 7Nisho Y,Kashiwagi A.Molecular mechanisms of endothelial dysfuntion in diabetes mellitus[J].Japanese Journal of Clinical Medcine Nippon Rinsno,2001,59(12):2451~2459
  • 8陆志明,余叶蓉.胰岛素抵抗与凝血、纤溶功能异常的关系[J].医学研究生学报,2003,16(11):864-865. 被引量:10
  • 9李焱.炎症与胰岛素抵抗[J].中华糖尿病杂志(1006-6187),2005,13(2):81-82. 被引量:15
  • 10Senn JJ,Klover PJ,Nowak IA,et al.Suppressor of cytokine signaling-3(SOCS-3),a potential mediator of interleuking-6-ependent insulin resistance in hepatocytes[ J].J Biol Chem,2003,278(16):13740~13746

二级参考文献32

  • 1Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins. JAMA, 1998,279:1643-1650.
  • 2Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med,1999, 340:115-126.
  • 3Ridker PM, Hennekens CH, Buring JE, et al. C-reRetive protein,and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med, 2000, 342: 836-843.
  • 4Zwaka TP, Hombach V, Torzewski J. C-reactive protein mediated low density lipoprotein uptake by macrophages: implications for atheroschrosis . Circulation , 2001, 103: 1194-1197.
  • 5Hashimoto H, Kitagawa K, Hougaku H, et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation , 2001, 104: 63-67.
  • 6Sethi AA, Tybjaerg-Hansen A, Gronholdt ML, et al. Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebroveseular disease. Six casecontrol studies from the Copenhagen City Heart Study. Ann Intern Med, 2001,134:941-954.
  • 7Koenig W. Fibrinogen and coronary risk. Curr Cardiol Rep,1999,1 : 112-118.
  • 8Charmer KS, Pngh PJ . Interfering with healing: the benefits of intervention during acute myocardial infarction . Heart, 2001,85:620-622.
  • 9Di Napoli P, Taecardi AA, Oliver M, et al. Statins and stroke:evidence for cholesterol-independent effects. Eur Heart J, 2002,23:1908-1921.
  • 10Ikeda Y,Suehiro T,Nakamura T,et al.Clinical significance of the insulin resistance index as assessed by homeostasis model assessment[J].Endocrine,2001,48(1):81-86.

共引文献41

同被引文献36

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部